USPTO serial 79371712
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard W. Kline
Howard W. Kline Nath, Goldberg & Meyer112 S. West StreetAlexandria, VA 22314UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention of chronic viral infections in high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for regulating the immune system for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for use in organ transplantation for elimination of chronic viral infections; pharmaceutical preparations for the prevention of diseases of the immune system; immunosuppressants for use following transplantation to prevent graft rejection; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutic agents for treatment of bacterial infections; pharmaceutical preparations for immunity adjustment for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations containing stem cells for high-risk immunocompromised patients and transplant recipients; immunoassay reagents for medical use; pharmaceutical preparations for the treatment of viral diseases; anti-viral agents; protein synthesis inhibitors for high-risk immunocompromised patients and transplant recipients; regulatory proteins being pharmaceutical preparations for medical use for high-risk immunocompromised patients and transplant recipients; pharmaceutical drugs for high-risk immunocompromised patients and transplant recipients; antibacterial pharmaceuticals | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical use; medical diagnostic test instruments for use in immunoanalytical procedures; medical diagnostic testing apparatus for use in medical immunoassay procedures; medical devices for regenerating stem cells for medical purposes; medical apparatus for cell sampling; pharmaceutical instruments and apparatus provided empty used for the inhalation of pharmaceuticals | ACTIVE | — |
| 042 | Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparations and medications; carrying out clinical trials for pharmaceutical products; laboratory research on pharmaceutical preparations; consultancy in the field of drug research and development; software as a service (SAAS) services featuring software for gathering, tracking, analyzing and activating data in relation to transformative therapies for high-risk immunocompromised patients and transplant recipients | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 14, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 22, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 22, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 11, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 11, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 26, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 19, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 14, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |